academic article

• Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia..  Haematologica.  :-. 2015
• Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers..  Leukemia research.  38:91-94. 2014
• Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia..  Leukemia.  1543-1545. 2014
• Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome?.  Seminars in oncology.  40:403-418. 2013
• Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine..  Leukemia research.  32:1043-1048. 2008
• Advances in the therapy of chronic idiopathic myelofibrosis..  The oncologist.  11:929-943. 2006
• [Intestinal effects of Buerger's disease (thromboangiitis obliterans) case report]..  Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú.  23:138-141. 2003